Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Biomarin Pharmaceutical Inc

Biomarin Pharmaceutical Inc (BMRN)

Market is closed
News
5 Best Biotech Stocks To Buy According To Hedge Funds

5 Best Biotech Stocks To Buy According To Hedge Funds

United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company engaged in the development and commercialization of medical products and therapies to address the unmet needs of patients with ...

Keep Reading →

November 25th, 2022 - Hedge Funds News

Should You Invest in BioMarin Pharmaceutical (BMRN)?

Should You Invest in BioMarin Pharmaceutical (BMRN)?

Carillon Tower Advisers, an investment management company, released its “Carillon Scout Mid Cap Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

October 7th, 2022 - Hedge Fund Investor Letters News

Top 10 Stock Picks of Roberto Mignone's Bridger Management

Top 10 Stock Picks of Roberto Mignone's Bridger Management

In this article, we discuss the top 10 stock picks of Roberto Mignone's Bridger Management.

Keep Reading →

September 15th, 2022 - Hedge Funds News

5 Best Biotech Stocks To Buy Now

5 Best Biotech Stocks To Buy Now

In this article, we discuss 5 Best Biotech Stocks To Buy Now.

Keep Reading →

August 29th, 2022 - Hedge Funds News

5 Best Healthcare Stocks To Buy Now According To Motley Fool’s 1623 Capital

5 Best Healthcare Stocks To Buy Now According To Motley Fool’s 1623 Capital

In this article, we talk about the 5 best healthcare stocks to buy now according to Motley Fool's 1623 Capital.

Keep Reading →

July 20th, 2022 - Hedge Funds News

Did Hedge Funds Catch A Break With BioMarin Pharmaceutical Inc. (BMRN)?

Did Hedge Funds Catch A Break With BioMarin Pharmaceutical Inc. (BMRN)?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

February 6th, 2022 - Hedge Funds News

10 Jim Cramer Stocks to Buy in Q1 2022

10 Jim Cramer Stocks to Buy in Q1 2022

Investors have been scrambling to identify the “real value” of stocks as reports suggest that as many as four interest rate hikes by the Federal Reserve are on the horizon for 2022.

Keep Reading →

January 19th, 2022 - Hedge Funds News

Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?

Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...

Keep Reading →

December 7th, 2021 - Hedge Funds News

10 Healthcare and Software Stocks to Buy According to Michel Massoud’s Melqart Asset Management

10 Healthcare and Software Stocks to Buy According to Michel Massoud’s Melqart Asset Management

In this article, we take a look at the 10 healthcare and software stocks to buy according to Michel Massoud’s Melqart Asset Management.

Keep Reading →

October 27th, 2021 - Hedge Fund Analysis Hedge Funds News

5 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors

5 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors

In this article, we will discuss 5 biotech and pharmaceutical stocks to buy according to Palo Alto Investors based on Q2 holdings of the fund.

Keep Reading →

October 21st, 2021 - Hedge Funds News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)